Showing all 2 results
Medroxyprogesterone Acetate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Micronized Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the delicate steroid molecule.
Active Ingredient Strength Primary Clinical Function Medroxyprogesterone Acetate USP/Ph.Eur. 2.5 mg / 5 mg HRT Maintenance Standard: Continuous or sequential low-dose therapy for the prevention of endometrial hyperplasia in postmenopausal women receiving estrogen. Medroxyprogesterone Acetate USP/Ph.Eur. 10 mg Acute Gynecology Standard: High-efficacy adult dosing for the rapid arrest of abnormal uterine bleeding and the induction of withdrawal bleeding in secondary amenorrhea. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Crospovidone / Magnesium Stearate Diluent / Binder / Superdisintegrant / Lubricant (Engineered specifically utilizing advanced micronized API to overcome the severe hydrophobicity of the steroid, ensuring maximum, predictable gastric absorption) *Pack Sizes: 10×10 Blisters or 14-Day Calendar Packs (Optimized specifically for strict cyclic or continuous gynecological dispensing regimens).
Medroxyprogesterone Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Aqueous Suspension in glass vials or prefilled syringes.
Active Ingredient Strength Volume Medroxyprogesterone Acetate USP/BP 150 mg 1 ml Vial (Standard Contraceptive) Medroxyprogesterone Acetate USP/BP 500 mg / 1000 mg High-Dose (Oncology Use) Excipients Polyethylene Glycol / Polysorbate 80 Suspending Agents *Pack Sizes: Single Vial with Syringe, or Tray of 25/50 Vials for Tenders.
